HuMax-CD4 in Non-Cutaneous T-Cell Lymphoma

NCT00877656 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

21

Enrollment

INDUSTRY

Sponsor class

Conditions

T Cell Lymphoma

Interventions

BIOLOGICAL: HuMax-CD4

Sponsor

Emergent BioSolutions